Product image of Jablerdiz (Cytisinicline) supplied by GNH India

Jablerdiz

Active Ingredient:
Cytisinicline
Origin:
EU

Jablerdiz (Cytisinicline)

Cytisinicline, the active ingredient in Jablerdiz, is a nicotinic acetylcholine receptor partial agonist presented as a tablet for oral use. It is used to aid smoking cessation in adults who are motivated to quit nicotine use.

GNH India supplies Jablerdiz as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Manufacturer / TM Owner

Adamed Pharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Jablerdiz is a nicotinic receptor partial agonist indicated for smoking cessation. It helps reduce nicotine cravings and withdrawal symptoms in individuals attempting to quit smoking.

  • Smoking cessation: reduces cravings and withdrawal symptoms, supporting abstinence from tobacco.
  • Nicotine dependence: assists adults in managing dependence on nicotine during quit attempts.
  • Relapse prevention: helps maintain abstinence by moderating nicotine‑related urges.

How It Works

  • Cytisinicline acts as a partial agonist at the α4β2 subtype of nicotinic acetylcholine receptors in the central nervous system. By binding to these receptors, it provides a moderate level of stimulation that diminishes the reinforcing effects of nicotine, thereby lowering cravings and easing withdrawal while limiting the full activation that would occur with nicotine itself.

Side Effects

Cytisinicline may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient tension‑type headache.
  • Insomnia: difficulty falling or staying asleep.
  • Vivid dreams: unusually intense or memorable dreams.
  • Dry mouth: reduced salivation.
  • Dizziness: light‑headed sensation.

Serious or Rare Side Effects

  • Mood changes: depression or anxiety worsening.
  • Seizures: rare convulsive episodes.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Cardiovascular events: hypertension or arrhythmia.
  • Psychiatric symptoms: hallucinations or psychosis.
  • Liver enzyme elevation: abnormal liver function tests.

Precautions & Warnings

Before prescribing Jablerdiz, clinicians should consider several safety aspects.

  • Cardiovascular assessment: evaluate blood pressure and heart disease history.
  • Neuropsychiatric monitoring: watch for mood or anxiety changes.
  • Hypertension caution: avoid use in uncontrolled high blood pressure.
  • Withdrawal counseling: advise patients about possible nicotine withdrawal symptoms.
  • Concomitant medication review: check for interactions with other CNS agents.
  • Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Cytisinicline can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors: risk of hypertensive crisis.
  • Strong CYP2A6 inhibitors: may increase Cytisinicline plasma levels.

Moderate Interactions (Monitor Closely)

  • Nicotine replacement therapy: additive nicotine effects may increase side‑effects.
  • Antidepressants (SSRIs, SNRIs): potential for serotonin syndrome.
  • Antihypertensives: possible reduction in blood pressure control.
  • Antiepileptic drugs: may alter seizure threshold.

Frequently Asked Questions

Jablerdiz contains Cytisinicline and is used as a prescription medication to help adults quit smoking. It works by reducing nicotine cravings and easing withdrawal symptoms, supporting individuals who are motivated to stop using tobacco products.

Cytisinicline is a partial agonist at the α4β2 nicotinic acetylcholine receptors in the brain. By partially stimulating these receptors, it provides enough activation to lessen nicotine cravings while preventing the full stimulant effect of nicotine, thereby helping to manage dependence.

The specific dose and dosing schedule of Jablerdiz are determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the prescriber’s instructions exactly.

Safety data for Cytisinicline in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing Jablerdiz to pregnant or breastfeeding individuals, and alternative treatments may be considered.

To request Jablerdiz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Jablerdiz (Cytisinicline) belongs to the class of nicotinic receptor partial agonists, similar to varenicline but with a distinct binding profile. It may offer comparable efficacy in reducing cravings while presenting a different side‑effect spectrum, which can influence the choice of therapy based on patient tolerance and physician preference.

Jablerdiz should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Jablerdiz is taken orally, typically as a tablet, with or without food as directed by the prescriber. The exact administration schedule, including timing and duration, should follow the healthcare professional’s guidance.

Serious risks include mood alterations such as depression or anxiety, rare seizures, severe allergic reactions, and cardiovascular events like hypertension. Patients should seek immediate medical attention if they experience any of these symptoms.

Jablerdiz is contraindicated in individuals with known hypersensitivity to Cytisinicline or any tablet excipients, and it should be used with caution in patients with uncontrolled hypertension, severe psychiatric disorders, or a history of seizures. The prescriber will assess suitability on a case‑by‑case basis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cytisinicline

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT